Growth momentum Uniphar Group posted 2025 revenue of €3.1bn with an 11% uplift and profit before tax of €71.8m, indicating strong financial health and capacity for scaled partnerships or long-term service engagements in pharmaceutical manufacturing and healthcare services.

Geographic expansion Active presence across Ireland, UK, Europe, the USA and APAC suggests opportunities for cross-border service contracts, supply chain optimization projects, and regionalized support solutions for global pharma clients.

Strategic acquisitions Recent acquisition of TouchStore expands dispensing and retail management software capabilities, opening access to pharmacy automation, digital readiness projects, and integrated software solutions for pharmacy networks.

Partnership potential Expansion of Orphan ClinDevNet with Uniphar as a strategic partner signals openness to collaborative development programs, rare disease treatment access initiatives, and joint ventures that leverage Uniphar’s logistics and commercialization strengths.

Technology leverage Adoption of SAP FICO, Power Platform, Power BI, Azure AI Services, ServiceNow and security tools positions Uniphar to offer data-driven operations optimization, financial governance improvements, and digital transformation services to pharma manufacturers and wholesalers.